Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
157.77
+2.84 (1.83%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Palvella Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $270 | Buy | Maintains | $270 | +71.14% | Aug 5, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $210 | Buy | Reiterates | $210 | +33.11% | Aug 5, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates $210 → $207 | Buy | Reiterates | $210 → $207 | +31.20% | Aug 5, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $225 → $236 | Buy | Maintains | $225 → $236 | +49.58% | Aug 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $227 → $232 | Buy | Maintains | $227 → $232 | +47.05% | Aug 5, 2026 |
| BTIG | BTIG | Buy Maintains $215 | Buy | Maintains | $215 | +36.27% | Aug 5, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $267 | Buy | Maintains | $267 | +69.23% | Aug 5, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $240 | Buy | Reiterates | $240 | +52.12% | Jul 1, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.